PD-1-M1-NK Cells 비교 | 바이오정보모아

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

Overview Toxicology Clinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목	CGTStandard DatabasestalePhase 1 PD-1-M1-NK Cells (PD-1-M1-NK Cells) jiuwei cui·PD-1 1 trials

Overview Program	PD-1-M1-NK Cells
Overview Company	jiuwei cui
Overview Modality	CGT
Overview Target	PD-1
Overview Indication	Advanced Gastric or Colorectal Cancer
Overview Phase	PHASE_1
Overview Status	RECRUITING
Overview Content status	Standard Database
Overview Data Confidence	Data Confidence · Medium
Overview Development Signal	Development Signal · Watch
Overview Approval status	Investigational

Toxicology Major finding	Acidic-responsive nano liposomes potentiate in situ dual immunotherapy on lung cancer by codelivering antagonistic peptide and agonist.. Current immunotherapies represent a highly promising approach for the treatment of lung cancer. However, their clinical efficacy is often constrained by T cell exhaustion, antibody resistance, and poor tumor penetration, highlighting an urgent need for innovative…

Clinical Safety signal	Acidic-responsive nano liposomes potentiate in situ dual immunotherapy on lung cancer by codelivering antagonistic peptide and agonist.. Current immunotherapies represent a highly promising approach for the treatment of lung cancer. However, their clinical efficacy is often constrained by T cell exhaustion, antibody resistance, and poor tumor penetration, highlighting an urgent need for innovative…
Clinical Program phase	PHASE_1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

Overview Toxicology Clinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목	CGTStandard DatabasestalePhase 1 PD-1-M1-NK Cells (PD-1-M1-NK Cells) jiuwei cui·PD-1 1 trials

Overview Program	PD-1-M1-NK Cells
Overview Company	jiuwei cui
Overview Modality	CGT
Overview Target	PD-1
Overview Indication	Advanced Gastric or Colorectal Cancer
Overview Phase	PHASE_1
Overview Status	RECRUITING
Overview Content status	Standard Database
Overview Data Confidence	Data Confidence · Medium
Overview Development Signal	Development Signal · Watch
Overview Approval status	Investigational

Toxicology Major finding	Acidic-responsive nano liposomes potentiate in situ dual immunotherapy on lung cancer by codelivering antagonistic peptide and agonist.. Current immunotherapies represent a highly promising approach for the treatment of lung cancer. However, their clinical efficacy is often constrained by T cell exhaustion, antibody resistance, and poor tumor penetration, highlighting an urgent need for innovative…

Clinical Safety signal	Acidic-responsive nano liposomes potentiate in situ dual immunotherapy on lung cancer by codelivering antagonistic peptide and agonist.. Current immunotherapies represent a highly promising approach for the treatment of lung cancer. However, their clinical efficacy is often constrained by T cell exhaustion, antibody resistance, and poor tumor penetration, highlighting an urgent need for innovative…
Clinical Program phase	PHASE_1